{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:07:10Z","timestamp":1758636430363},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"BMBF","award":["0315765","0315769"],"award-info":[{"award-number":["0315765","0315769"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s40360-017-0155-4","type":"journal-article","created":{"date-parts":[[2017,6,26]],"date-time":"2017-06-26T14:59:35Z","timestamp":1498489175000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Modulation of hepatic perfusion did not improve recovery from hepatic outflow obstruction"],"prefix":"10.1186","volume":"18","author":[{"given":"J.","family":"Arlt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Homeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Settmacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Dahmen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Dirsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,26]]},"reference":[{"key":"155_CR1","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/0016-5085(85)90214-8","volume":"89","author":"JN Benoit","year":"1985","unstructured":"Benoit JN, et al. \u201cForward\u201d and \u201cbackward\u201d flow mechanisms of portal hypertension. Relative contributions in the rat model of portal vein stenosis. Gastroenterology. 1985;89:1092\u20136.","journal-title":"Gastroenterology"},{"key":"155_CR2","unstructured":"Henderson JM. Bock Gastrointestinal Surgery - Portal Hypertension. Section 3, chapter 12. https:\/\/de.scribd.com\/document\/181940159\/9780723430698-pdf . Accessed 16 Nov 2015."},{"key":"155_CR3","first-page":"549","volume":"249","author":"WW Lautt","year":"1985","unstructured":"Lautt WW. Mechanism and role of intrinsic regulation of hepatic arterial blood flow: the hepatic arterial buffer response. Am J Physiol. 1985;249:549\u201356.","journal-title":"Am J Physiol"},{"key":"155_CR4","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1097\/TP.0b013e31816631f9","volume":"85","author":"O Dirsch","year":"2008","unstructured":"Dirsch O, et al. Recovery of liver perfusion after focal outflow obstruction and liver resection. Transplantation. 2008;85:748\u201356. doi: 10.1097\/TP.0b013e31816631f9 .","journal-title":"Transplantation"},{"key":"155_CR5","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1111\/j.1600-6143.2011.03682.x","volume":"11","author":"H Huang","year":"2011","unstructured":"Huang H, et al. Hepatic arterial perfusion is essential for the spontaneous recovery from focal hepatic venous outflow obstruction in rats. Am J Transplant. 2011;11:2342. doi: 10.1111\/j.1600-6143.2011.03682.x .","journal-title":"Am J Transplant"},{"key":"155_CR6","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1097\/TP.0000000000000089","volume":"97","author":"H Huang","year":"2014","unstructured":"Huang H, et al. Reduced hepatic arterial perfusion impairs the recovery from focal hepatic venous outflow obstruction in liver-resected rats. Transplantation. 2014;97:1009\u201318. doi: 10.1097\/TP.0000000000000089 .","journal-title":"Transplantation"},{"key":"155_CR7","first-page":"282","volume":"104","author":"T Ikegami","year":"2013","unstructured":"Ikegami T, et al. Application of splenectomy to decompress portal pressure in left lobe living donor liver transplantation. Fukuoka Igaku Zasshi. 2013;104:282\u20139.","journal-title":"Fukuoka Igaku Zasshi"},{"key":"155_CR8","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/S0039","volume":"134","author":"ER Winslow","year":"2003","unstructured":"Winslow ER, et al. Perioperative outcomes of laparoscopic versus open splenectomy: A meta-analysis with an emphasis on complications. Surgery. 2003;134:647\u201353. doi: 10.1016\/S0039 .","journal-title":"Surgery"},{"key":"155_CR9","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00268-006-0504-8","volume":"31","author":"Y Watanabe","year":"2007","unstructured":"Watanabe Y, et al. Significance of Laparoscopic Splenectomy in Patients with Hypersplenism. World J Surg. 2007;31:549\u201355. doi: 10.1007\/s00268-006-0504-8 .","journal-title":"World J Surg"},{"key":"155_CR10","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jamcollsurg.2012.11.011","volume":"216","author":"T Ikegami","year":"2013","unstructured":"Ikegami T, et al. Strategies for successful left-lobe living donor liver transplantation in 250 consecutive adult cases in a single center. J Am Coll Surg. 2013;216:353\u201362. doi: 10.1016\/j.jamcollsurg.2012.11.011 .","journal-title":"J Am Coll Surg"},{"key":"155_CR11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.1365-2036.2002.01190.x","volume":"16","author":"D Tripathi","year":"2002","unstructured":"Tripathi D, et al. Haemodynamic effects of acute and chronic administration of low-dose carvedilol, a vasodilating b-blocker, in patients with cirrhosis and portal hypertension. Aliment Pharmacol Ther. 2002;16:373\u201380.","journal-title":"Aliment Pharmacol Ther"},{"key":"155_CR12","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/0016-5085(89)91630-2","volume":"96","author":"M Navasa","year":"1989","unstructured":"Navasa M, et al. Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Effects on splanchnic and systemic hemodynamics and liver function. Gastroenterology. 1989;96:1110\u20138.","journal-title":"Gastroenterology"},{"key":"155_CR13","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/00000542-200609000-00026","volume":"105","author":"TA Treschan","year":"2006","unstructured":"Treschan TA, Peters J. The vasopressin system: physiology and clinical strategies. Anesthesiology. 2006;105:599\u2013612.","journal-title":"Anesthesiology"},{"key":"155_CR14","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1056\/NEJM199601253340408","volume":"334","author":"SWJ Lamberts","year":"2006","unstructured":"Lamberts SWJ, et al. Octreotide. N Engl J Med. 2006;334:246\u201354.","journal-title":"N Engl J Med"},{"key":"155_CR15","first-page":"213","volume":"28","author":"S Das","year":"2002","unstructured":"Das S, et al. Cardioprotection with sildenafil, a selective inhibitor of cyclic 3\u2032,5\u2032-monophosphate-specific phosphodiesterase 5. Drugs Exp Clin Res. 2002;28:213\u20139.","journal-title":"Drugs Exp Clin Res"},{"key":"155_CR16","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1258\/la.2009.009055","volume":"44","author":"H Huang","year":"2010","unstructured":"Huang H, et al. Intraoperative vital and haemodynamic monitoring using an integrated multiple-channel monitor in rats. Lab Anim. 2010;44:254\u201363. doi: 10.1258\/la.2009.009055 .","journal-title":"Lab Anim"},{"key":"155_CR17","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1097\/01.tp.0000226064.43949.9e","volume":"81","author":"O Dirsch","year":"2006","unstructured":"Dirsch O, et al. Influence of stem cell mobilization and liver regeneration on hepatic parenchymal chimerism in the rat. Transplantation. 2006;81:1695. doi: 10.1097\/01.tp.0000226064.43949.9e .","journal-title":"Transplantation"},{"key":"155_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/PAI.0000000000000120","volume":"24","author":"J Arlt","year":"2016","unstructured":"Arlt J, et al. One size fits all: evaluation of the transferability of a new \u201clearning\u201d histologic image analysis application. Appl Immunohistochem Mol Morphol. 2016;24:1\u201310. doi: 10.1097\/PAI.0000000000000120 .","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"155_CR19","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.compmedimag.2013.05.002","volume":"37","author":"A Homeyer","year":"2013","unstructured":"Homeyer A, et al. Practical quantification of necrosis in histological whole-slide images. Comput Med Imaging Graph. 2013;37:313\u201322. doi: 10.1016\/j.compmedimag.2013.05.002 .","journal-title":"Comput Med Imaging Graph"},{"key":"155_CR20","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1159\/000090333","volume":"37","author":"M Glanemann","year":"2005","unstructured":"Glanemann M, et al. Hyperperfusion syndrome in small-for-size livers. Eur Surg Res. 2005;37:335\u201341. doi: 10.1159\/000090333 .","journal-title":"Eur Surg Res"},{"key":"155_CR21","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1440-1746.1997.tb00526.x","volume":"12","author":"A Ogata","year":"1997","unstructured":"Ogata A, et al. Short-term effect of portal vein arterialization on hepatic protein synthesis and endotoxaemia after extended hepatectomy in dogs. J Gastroenterol Hepatol. 1997;12:633\u20138.","journal-title":"J Gastroenterol Hepatol"},{"key":"155_CR22","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1111\/hpb.12434","volume":"17","author":"B Darnis","year":"2015","unstructured":"Darnis B, et al. Subtotal hepatectomy in swine for studying small-for-size syndrome and portal inflow modulation: is it reliable? HPB. 2015;17:881\u20138. doi: 10.1111\/hpb.12434 .","journal-title":"HPB"},{"key":"155_CR23","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1111\/j.1432-2277.2010.01079.x","volume":"23","author":"C Eipel","year":"2010","unstructured":"Eipel C, et al. Splenectomy improves survival by increasing arterial blood supply in a rat model of reduced-size liver. Eur Soc Org Transplan. 2010;23:998\u20131007. doi: 10.1111\/j.1432-2277.2010.01079.x .","journal-title":"Eur Soc Org Transplan"},{"key":"155_CR24","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s00595-014-0999-9","volume":"45","author":"H Wang","year":"2015","unstructured":"Wang H, et al. Optimal changes in portal hemodynamics induced by splenectomy during living donor liver transplantation. Surg Today. 2015;45:979\u201385. doi: 10.1007\/s00595-014-0999-9 .","journal-title":"Surg Today"},{"key":"155_CR25","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1002\/bjs.9622","volume":"101","author":"H Kawanaka","year":"2014","unstructured":"Kawanaka H, et al. Effect of laparoscopic splenectomy on portal haemodynamics in patients with liver cirrhosis and portal hypertension. Br J Surg. 2014;101:1585\u201393. doi: 10.1002\/bjs.9622 .","journal-title":"Br J Surg"},{"key":"155_CR26","first-page":"871","volume":"92","author":"PW Lin","year":"1993","unstructured":"Lin PW, et al. Effects of splenectomy, devascularization and esophageal transection on portal venous pressure and portal perfusion in cirrhotic patients with bleeding esophageal varices. J Formos Med Assoc. 1993;92:871\u20135.","journal-title":"J Formos Med Assoc"},{"key":"155_CR27","doi-asserted-by":"crossref","unstructured":"T. Yoichi et al., Protective effects of simultaneous splenectomy on small-for-size liver graft injury in rat liver transplantation. John Wiley & Sons Ltd, 2014, 27:106\u2013113 doi: 10.1111\/tri.12223.","DOI":"10.1111\/tri.12223"},{"key":"155_CR28","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/lt.23519","volume":"18","author":"N Kuriyama","year":"2012","unstructured":"Kuriyama N, et al. Dual cytoprotective effects of splenectomy for small-for-size liver transplantation in rats. Liver Transpl. 2012;18:1361\u201370. doi: 10.1002\/lt.23519 .","journal-title":"Liver Transpl"},{"key":"155_CR29","doi-asserted-by":"crossref","first-page":"6046","DOI":"10.3748\/wjg.v16.i48.6046","volume":"16","author":"C Eipel","year":"2010","unstructured":"Eipel C, et al. Regulation of hepatic blood flow: The hepatic arterial buffer response revisited. World J Gastroenterol. 2010;16:6046\u201357.","journal-title":"World J Gastroenterol"},{"key":"155_CR30","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00535-006-1782-5","volume":"41","author":"HC Lin","year":"2006","unstructured":"Lin HC, et al. Hemodynamic effects of one week of carvedilol administration on cirrhotic rats. J Gastroenterol. 2006;41:361\u20138. doi: 10.1007\/s00535-006-1782-5 .","journal-title":"J Gastroenterol"},{"key":"155_CR31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10787-009-0027-7","volume":"18","author":"OM Abdel Salam","year":"2010","unstructured":"Abdel Salam OM, et al. Hepatoprotective effects of the nitric oxide donor isosorbide-5-mononitrate alone and in combination with the natural hepatoprotectant, silymarin, on carbon tetrachloride-induced hepatic injury in rats. Inflammopharmacology. 2010;18:87\u201394. doi: 10.1007\/s10787-009-0027-7 .","journal-title":"Inflammopharmacology"},{"key":"155_CR32","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1056\/NEJM199812103392407","volume":"339","author":"WH Frishman","year":"1998","unstructured":"Frishman WH. Carvedilol. N Engl J Med. 1998;339:1759\u201365. doi: 10.1056\/NEJM199812103392407 .","journal-title":"N Engl J Med"},{"key":"155_CR33","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.niox.2012.03.008","volume":"26","author":"SA Omar","year":"2012","unstructured":"Omar SA, et al. A comparison of organic and inorganic nitrates\/nitrites. Nitric Oxide. 2012;26:229\u201340. doi: 10.1016\/j.niox.2012.03.008 .","journal-title":"Nitric Oxide"},{"key":"155_CR34","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1007\/BF01308328","volume":"25","author":"AT Blei","year":"1980","unstructured":"Blei AT, et al. Comparison of vasopressin and triglycyl-lysine vasopressin on splanchnic and systemic hemodynamics in dogs. Dig Dis Sci. 1980;25:688\u201394.","journal-title":"Dig Dis Sci"},{"key":"155_CR35","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.dld.2004.04.005","volume":"36","author":"F Piscaglia","year":"2004","unstructured":"Piscaglia F, et al. Different haemodynamic effects of a single dose of long-acting isosorbide-5-mononitrate in healthy subjects and patients with cirrhotic portal hypertension. Dig Liver Dis. 2004;36:594\u2013602. doi: 10.1016\/j.dld.2004.04.005 .","journal-title":"Dig Liver Dis"},{"key":"155_CR36","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0168-8278(96)80162-0","volume":"24","author":"A Escorsell","year":"1996","unstructured":"Escorsell A, et al. Effects of isosorbide-5-mononitrate on variceal pressure and systemic and splanchnic haemodynamics in patients with cirrhosis. J Hepatol. 1996;24:423\u20139.","journal-title":"J Hepatol"},{"key":"155_CR37","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0168-8278(05)80503-3","volume":"20","author":"RD Grose","year":"1994","unstructured":"Grose RD, et al. The acute and chronic effects of isosorbide-5-mononitrate on portal haemodynamics in cirrhosis. J Hepatol. 1994;20:542\u20137.","journal-title":"J Hepatol"},{"key":"155_CR38","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0168-8278(90)90112-5","volume":"11","author":"JC Garcia-Pag\u00e1n","year":"1990","unstructured":"Garcia-Pag\u00e1n JC, et al. Long-term haemodynamic effects of isosorbide 5-mononitrate in patients with cirrhosis and portal hypertension. J Hepatol. 1990;11:189\u201395.","journal-title":"J Hepatol"},{"key":"155_CR39","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1136\/gut.36.1.104","volume":"36","author":"AL Jones","year":"1995","unstructured":"Jones AL, et al. Portal and systemic haemodynamic response to acute and chronic administration oflow and high dose isosorbide-5-mononitrate in patients with cirrhosis. Gut. 1995;36:104\u20139.","journal-title":"Gut"},{"key":"155_CR40","first-page":"330","volume":"31","author":"L Moleda","year":"2013","unstructured":"Moleda L, Wiest R. Portale hypertension, pharmakologische therapieans\u00e4tze. Arzneimitteltherapie. 2013;31:330\u201341.","journal-title":"Arzneimitteltherapie"},{"key":"155_CR41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/clpt.1987.6","volume":"41","author":"LX Cubeddu","year":"1987","unstructured":"Cubeddu LX, et al. Clinical pharmacology of carvedilol in normal volunteers. Clin Pharm Ther. 1987;41:31\u201344.","journal-title":"Clin Pharm Ther"},{"key":"155_CR42","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0168-8278(96)80296-0","volume":"25","author":"EH Forrest","year":"1996","unstructured":"Forrest EH, et al. Acute haemodynamic changes after oral carvedilol, a vasodilating beta-blocker, in patients with cirrhosis. J Hepatol. 1996;25:909\u201315.","journal-title":"J Hepatol"},{"key":"155_CR43","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/hep.510300124","volume":"30","author":"R Ba\u00f1ares","year":"1999","unstructured":"Ba\u00f1ares R, et al. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis. Hepatology. 1999;30:79\u201383. doi: 10.1002\/hep.510300124 .","journal-title":"Hepatology"},{"key":"155_CR44","first-page":"467","volume":"49","author":"V Silkauskait\u0117","year":"2013","unstructured":"Silkauskait\u0117 V, et al. Acute and 14-day hepatic venous pressure gradient response to carvedilol and nebivolol in patients with liver cirrhosis. Medicina (Kaunas). 2013;49:467\u201373.","journal-title":"Medicina (Kaunas)"},{"key":"155_CR45","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3109\/00365521.2012.666673","volume":"47","author":"L Hobolth","year":"2012","unstructured":"Hobolth L, et al. Carvedilol or propranolol in portal hypertension? A randomized comparison. Scand J Gastroenterol. 2012;47:467\u201374. doi: 10.3109\/00365521.2012.666673 .","journal-title":"Scand J Gastroenterol"},{"key":"155_CR46","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1111\/j.1572-0241.2004.40179.x","volume":"99","author":"HC Lin","year":"2004","unstructured":"Lin HC, et al. Acute administration of carvedilol is more effective than propranolol plus isosorbide-5-mononitrate in the reduction of portal pressure in patients with viral cirrhosis. Am J Gastroenterol. 2004;99:1953\u20138. doi: 10.1111\/j.1572-0241.2004.40179.x .","journal-title":"Am J Gastroenterol"},{"key":"155_CR47","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1053\/jhep.2002.36947","volume":"36","author":"R Ba\u00f1ares","year":"2002","unstructured":"Ba\u00f1ares R, et al. Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis. Hepatology. 2002;36:1367\u201373. doi: 10.1053\/jhep.2002.36947 .","journal-title":"Hepatology"},{"key":"155_CR48","doi-asserted-by":"crossref","unstructured":"A. Bhardwaj et al. Carvedilol delays the progression of small oesophageal varices in patients with cirrhosis: a randomised placebo-controlled trial. Gut, 2016, 0: 1\u20136 doi: 10.1136\/gutjnl-2016-311735.","DOI":"10.1136\/gutjnl-2016-311735"},{"key":"155_CR49","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0168-8278(00)80422-5","volume":"32","author":"J Bosch","year":"2000","unstructured":"Bosch J, et al. Complications of cirrhosis. I. Portal hypertension. J Hepatol. 2000;32:141\u201356.","journal-title":"J Hepatol"},{"key":"155_CR50","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/S0168-8278(00)80320-7","volume":"33","author":"R Franchis De","year":"2000","unstructured":"De Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol. 2000;33:846\u201352.","journal-title":"J Hepatol"},{"key":"155_CR51","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.jhep.2010.06.004","volume":"53","author":"R Franchis De","year":"2010","unstructured":"De Franchis R, et al. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2010;53:762\u20138. doi: 10.1016\/j.jhep.2010.06.004 .","journal-title":"J Hepatol"},{"key":"155_CR52","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1034\/j.1600-0676.2000.020001051.x","volume":"20","author":"S M\u00f9ller","year":"2000","unstructured":"M\u00f9ller S, et al. Central and systemic haemodynamic effects of terlipressin in portal hypertensive patients. Liver. 2000;20:51\u20139.","journal-title":"Liver"},{"key":"155_CR53","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1111\/j.1440-1746.2009.05873.x","volume":"24","author":"Y Narahara","year":"2009","unstructured":"Narahara Y, et al. Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis. J Gastroenterol Hepatol. 2009;24:1791\u20137. doi: 10.1111\/j.1440-1746.2009.05873.x .","journal-title":"J Gastroenterol Hepatol"},{"key":"155_CR54","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/j.1572-0241.2005.41381.x","volume":"100","author":"SK Baik","year":"2005","unstructured":"Baik SK, et al. Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison. Am J Gastroenterol. 2005;100:631\u20135. doi: 10.1111\/j.1572-0241.2005.41381.x .","journal-title":"Am J Gastroenterol"},{"key":"155_CR55","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0168-8278(05)80529-X","volume":"17","author":"D Lebrec","year":"2009","unstructured":"Lebrec D, et al. Effects of terlipressin on hemodynamics and oxygen content in conscious portal vein stenosed and cirrhotic rats receiving propranolol. J Hepatol. 2009;17:102\u20137.","journal-title":"J Hepatol"},{"key":"155_CR56","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0168-8278(98)80184-0","volume":"29","author":"F Oberti","year":"1998","unstructured":"Oberti F, et al. Hemodynamic effects of terlipressin and octreotide administration alone or in combination in portal hypertensive rats. J Hepatol. 1998;29:103\u201311.","journal-title":"J Hepatol"},{"key":"155_CR57","doi-asserted-by":"publisher","first-page":"208","DOI":"10.5754\/hge11288","volume":"59","author":"Z Ren","year":"2012","unstructured":"Ren Z, et al. The effect of terlipressin on hepatic hemodynamics in small-for-size livers. Hepatogastroenterology. 2012;59:208\u201311. doi: 10.5754\/hge11288 .","journal-title":"Hepatogastroenterology"},{"key":"155_CR58","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1097\/TP.0000000000000045","volume":"97","author":"R Fahrner","year":"2014","unstructured":"Fahrner R, et al. Elevated liver regeneration in response to pharmacological reduction of elevated portal venous pressure by terlipressin after partial hepatectomy. Transplantation. 2014;97:892\u2013900. doi: 10.1097\/TP.0000000000000045 .","journal-title":"Transplantation"},{"key":"155_CR59","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1053\/gast.2001.22529","volume":"120","author":"R Wiest","year":"2001","unstructured":"Wiest R, et al. Octreotide potentiates PKC-dependent vasoconstrictors in portal-hypertensive and control rats. Gastroenterology. 2001;120:975\u201383.","journal-title":"Gastroenterology"},{"key":"155_CR60","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0168-8278(05)80663-4","volume":"16","author":"SJ Hwang","year":"1992","unstructured":"Hwang SJ, et al. A randomized controlled trial comparing octreotide and vasopressin in the control of acute esophageal variceal hemorrhage. J Hepatol. 1992;16:320\u20135.","journal-title":"J Hepatol"},{"key":"155_CR61","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0016-5085(88)90242-9","volume":"94","author":"R Cerini","year":"1988","unstructured":"Cerini R, et al. Circulatory effects of somatostatin analogue in two conscious rats models of portal hypertension. Gastroenterology. 1988;94:703\u20138.","journal-title":"Gastroenterology"},{"key":"155_CR62","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/0016-5085(91)90411-D","volume":"101","author":"P Pizcueta","year":"1991","unstructured":"Pizcueta P, et al. Glucagon hinders the effects of somatostatin on portal hypertension. A study in rats with partial portal vein ligation. Gastroenterology. 1991;101:1710\u20135.","journal-title":"Gastroenterology"},{"key":"155_CR63","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/BF02361244","volume":"29","author":"N Hori","year":"1994","unstructured":"Hori N, et al. Hemodynamic effects of combined treatment with somatostatin analogue (SMS 201\u2013995) and low-dose isosorbide dinitrate on portal hypertension in conscious cirrhotic rats. J Gastroenterol. 1994;29:460\u20138.","journal-title":"J Gastroenterol"},{"key":"155_CR64","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/bjs.1800721105","volume":"72","author":"SA Jenkins","year":"1985","unstructured":"Jenkins SA, et al. The effects of somatostatin analogue SMS 201\u2013995 on hepatic haemodynamics in the cirrhotic rat. Br J Surg. 1985;72:864\u20137.","journal-title":"Br J Surg"},{"key":"155_CR65","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1002\/hep.510280612","volume":"28","author":"J Fort","year":"1998","unstructured":"Fort J, et al. Antifibrotic and hemodynamic effects of the early and chronic administration of octreotide in two models of liver fibrosis in rats. HEPATOLOGY. 1998;28:1525\u201331. doi: 10.1002\/hep.510280612 .","journal-title":"HEPATOLOGY"},{"key":"155_CR66","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/thx.2005.041954","volume":"60","author":"AA Aldashev","year":"2005","unstructured":"Aldashev AA, et al. Phosphodiesterase type 5 and high altitude pulmonary hypertension. Thorax. 2005;60:683\u20137. doi: 10.1136\/thx.2005.041954 .","journal-title":"Thorax"},{"key":"155_CR67","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/lt.23407","volume":"18","author":"TJ Hollatz","year":"2012","unstructured":"Hollatz TJ, et al. Treatment with sildenafil and treprostinil allows successful liver transplantation of patients with moderate to severe portopulmonary hypertension. Liver Transplant. 2012;18:686\u201395. doi: 10.1002\/lt.23407 .","journal-title":"Liver Transplant"},{"key":"155_CR68","doi-asserted-by":"publisher","first-page":"3274","DOI":"10.1161\/CIRCULATIONAHA.104.473371","volume":"111","author":"T Humpl","year":"2005","unstructured":"Humpl T, et al. Beneficial effect of oral sildenafil therapy on childhood pulmonary arterial hypertension: twelve-month clinical trial of a single-drug, open-label, pilot study. Circulation. 2005;111:3274\u201380. doi: 10.1161\/CIRCULATIONAHA.104.473371 .","journal-title":"Circulation"},{"key":"155_CR69","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1471-230X-9-69","volume":"9","author":"L Halverscheid","year":"2009","unstructured":"Halverscheid L, et al. Phosphodiesterase-5 inhibitors have distinct effects on the hemodynamics of the liver. BMC Gastroenterol. 2009;9:69. doi: 10.1186\/1471-230X-9-69 .","journal-title":"BMC Gastroenterol"},{"key":"155_CR70","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/j.transproceed.2012.04.003","volume":"44","author":"S Yardimci","year":"2012","unstructured":"Yardimci S, et al. Sildenafil accelerates liver regeneration after partial hepatectomy in rats. Transplant Proc. 2012;44:1747\u201350. doi: 10.1016\/j.transproceed.2012.04.003 .","journal-title":"Transplant Proc"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-017-0155-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T03:13:26Z","timestamp":1569554006000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-017-0155-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,26]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["155"],"URL":"https:\/\/doi.org\/10.1186\/s40360-017-0155-4","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,26]]},"article-number":"50"}}